American Regent Sodium Chloride Recall: Particulate Contamination
Visible particles found floating in vials has led to a recall of 21 lots of concentrated sodium chloride injections made by American Regent.
The sodium chloride recall was announced on March 15 by the FDA after the manufacturer discovered the problem and pulled the injections.
American Regent, Inc. says it has identified the source of the particulates and has made changes to correct the issue, however the company did not identify what the particles were made of, or how they got into the sodium chloride injections.
Did You Know?
Millions of Philips CPAP Machines Recalled
Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.Learn More
According to the company, the particulates could disrupt blood flow in the lung, and cause localized inflammation and granuloma formation. There have been no reports of illness or injury reported in connection to the contaminated sodium chloride injections.
The recall affects 16 lots of concentrated sodium chloride injection, USP 23.4% in 30 mL single dose vials with NDC# 0517-2930-25. Also being recalled are 5 lots of concentrated sodium chloride injection, USP 23.4% in 100 mL pharmacy bulk packages with NDC# 0517-2900-25. A complete list of lot numbers, expiration dates and distribution dates is available on the recall notice .
Concentrated sodium chloride injections are used to treat patients that have problems taking in or excreting sodium electrolytes.
This is the third recall of American Regent injectable drugs this year due to particulate contamination. In early January, the company issued an Acetadote recall affecting six lots. In early February one lot of sodium thiosulfate was recalled after flakes of glass were found in some vials.
American Regent says it will credit accounts for all customers affected by the recall. Healthcare providers or patients with questions should contact American Regent’s Professional Services Department at 1-877-788-3232. Anyone experiencing an adverse reaction is asked to report the problem to American Regent Inc. via e-mail at PV@luitpold.com. Adverse reactions should also be reported to the FDA’s MedWatch program online at www.fda.gov/medwatch/report.htm.
"*" indicates required fields
More Top Stories
More than 775 Exactech lawsuits have been filed in federal and state courts as parties work toward a plan for bellwether early test trials.
A federal judge has announced he will soon begin remanding 3M earplug lawsuits back to their originating districts for trials over claims of veteran hearing loss.
Lawyers are working to register and file Philips CPAP lawsuits, as the manufacturer may argue the June 14 anniversary of a massive recall triggered the start of the statute of limitations in certain states